Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2010
03/31/2010CN101687034A Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same
03/31/2010CN101684097A Phenylpyrimidine amines as ige inhibitors
03/31/2010CN101684089A bicycloester derivative
03/31/2010CN101683525A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/31/2010CN101683479A Chinese medicine oral liquid for preventing and treating sunstroke of laying hen and preparation method thereof
03/31/2010CN101683433A Preparation method of nourishing ointment containing sweet wheat and jujubes
03/31/2010CN101683365A Taditional Chinese medicine preparation for treating heatstroke and apoplexy
03/31/2010CN101683353A Preparation method and application of flavone and flavan derivatives
03/31/2010CN101683341A Levobupivacaine and levisoprenaline contained frozen dry powder preparation for injection
03/31/2010CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
03/31/2010CN101683317A 缓释组合物 Sustained release composition
03/31/2010CN101683303A Method for shaping face by point hitting
03/30/2010US7687664 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
03/30/2010US7687637 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687543 Use of polyunsaturated ketones for the treatment of psoriasis
03/30/2010US7687505 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687489 Agent for treatment of cerebral ischemic diseases
03/30/2010US7687480 Phosphonate compounds
03/30/2010US7687266 Pluripotency determining factors and uses thereof
03/30/2010CA2544963C Myo-inositol hexaphosphate for topical use technical field
03/30/2010CA2495537C Immunoregulatory compounds and derivatives and methods of treating diseases therewith
03/30/2010CA2472237C Multi-stage oral drug controlled-release system
03/30/2010CA2472028C Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
03/30/2010CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
03/30/2010CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
03/30/2010CA2436667C Novel bioactive substance
03/30/2010CA2420894C Thienopyrimidines
03/30/2010CA2418084C Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom
03/30/2010CA2405971C New piperazine and piperidine compounds
03/30/2010CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
03/30/2010CA2386850C Hexahydrofuro[2,3-b]furan-3-yl-n-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor
03/30/2010CA2374755C Mono- and disubstituted 3-propyl gamma-aminobutyric acids
03/30/2010CA2362277C Spontaneously dispersible n-benzoyl staurosporine compositions
03/30/2010CA2356404C Method for accelerating the rate of mucociliary clearance
03/30/2010CA2306429C Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors
03/30/2010CA2292792C Recombinant adenoviral vectors comprising a splicing sequence
03/30/2010CA2171207C Methods for regulating gastrointestinal motility
03/25/2010WO2010034015A2 Modulating the alternative complement pathway
03/25/2010WO2010033822A2 Therapeutic and diagnostic strategies
03/25/2010WO2010033598A2 System and method for utilizing microbubbles and liposomes as viral sequestering agents
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032816A1 Novel lysophosphatidylserine receptor
03/25/2010WO2010032764A1 Therapeutic/prophylactic agent for prostate cancer
03/25/2010WO2010032731A1 Benzimidazole compound in crystal form and salt thereof
03/25/2010WO2010032582A1 Therapeutic agent for adult t-cell leukemia
03/25/2010WO2010032448A1 Sheet for repairing cartilage defect site
03/25/2010WO2010032436A1 Antitumor agent containing 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid
03/25/2010WO2009117677A3 Controlling intracellular calcium levels associated with an ischemic event with o-desulfated heparin
03/25/2010US20100076055 Cationic Lipids and Uses Thereof
03/25/2010US20100076035 Transdermal Drug Delivery using an Osmolyte and Vasoactive Agent
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075906 Targeted Therapeutic Proteins
03/25/2010US20100075905 Novel cellular factor-containing solution compositions
03/25/2010US20100075903 Stable ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist suitable for intravitreal administration to the eye
03/25/2010US20100075896 Repair of larynx, trachea, and other fibrocartilaginous tissues
03/25/2010US20100075891 Novel polynucleotides encoding polypeptides and methods using same
03/25/2010US20100074964 Super brown cream
03/25/2010US20100074960 High-loading, controlled-release magnesium oral dosage forms and methods of making and using same
03/25/2010US20100074952 Tasted masked veterinary solid compositions
03/25/2010US20100074878 Probiotic bacterium: lactobacillus fermentum
03/25/2010US20100074850 Flavour Modulating Derivative of a Carboxylic Acid and a Purine, Pyrimidine, Nucleoside, or Nucleotide
03/24/2010EP2166020A1 Peptide having hypotensive activity
03/24/2010EP2166003A1 Excitatory amino acid receptor antagonists
03/24/2010EP2165715A1 Therapeutic agent for cancer, and method for treatment of cancer
03/24/2010EP2165605A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease
03/24/2010EP1003370B1 Method of enhancing magnesium absorption and prevention of atherosclerosis
03/24/2010CN101679962A Single-stranded cyclic rna, and method for production thereof
03/24/2010CN101679390A Ground crystal of olmesartan medoxomil
03/24/2010CN101679324A 吗啉衍生物 Morpholine derivatives
03/24/2010CN101679309A Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
03/24/2010CN101679243A atropisomer of pyrrole derivative
03/24/2010CN101678088A Modified mutant collagenase and it's use in fat melting and in scar reduction
03/24/2010CN101678082A Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies
03/24/2010CN101678077A Novel antiphlogistic-analgesic agent
03/24/2010CN101678071A Prophylactic agent for renal failure
03/24/2010CN101678037A Combined use of cholestanol derivative
03/24/2010CN101678006A Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
03/24/2010CN101678001A Combination therapy comprising AZD2171 and AZD6244 or MEK-inhibitor II
03/24/2010CN101677983A Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
03/24/2010CN101677931A Wrinkling-preventing and -modifying agent
03/24/2010CN101676285A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675922A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100595204C Bisamidate phosphonate prodrugs
03/24/2010CN100594928C Curcuma extract and its prepn process, medicine composition and use
03/24/2010CN100594926C Anti-microbial agent and anti-microbial composition
03/24/2010CN100594909C Therapeutic agent for hemorrhoidal disease
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683053 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1564